Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1494

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 7
Chunk 1494
---
 protection, antitrust laws across multiple countries including Korea, U.S.,
Germany, France, Japan, Poland, etc. Mr. Lee’s transactional experience includes managing over 300 deals in private equity
and real estate transactions. Mr. Lee currently holds the position of Managing Director at IGIS (May 2023-Present), the largest
real estate investment adviser in Korea (AUM US $48 billion). His previous roles include Chief Compliance Officer at IKR Co., Ltd.
(a joint venture between IGIS Asset Management and KKR & Co. Inc.) (February 2023 to April 2023), CEO of Tropics Private
Equity Co., Ltd. (2021-2023), Managing Director at KDS Asset Management Co., Ltd. (2020-2021), Head of Legal at Korea Investment Corporation
(2016-2019), Head of Legal at National Pension Service (2013-2016), and Head of Legal at Woori Asset Management Company (2011-2013). His
earlier career also includes positions at Joowon (a Korean law firm, 2009-2011); Biomass Korea (former KOSDAQ listed company, 2008-2009),
Franklin Templeton Investment Management Co., Ltd. (a wholly-owned subsidiary of Franklin Resources, Inc., a NYSE-listed company 2002-2007),
and Accenture (a NYSE-listed company 2000-2002). Mr. Lee earned a BA in Psychology from Korea University (1992), an MBA
from Haas School of Business, University of California at Berkeley (1995), and a JD from Syracuse University College of Law (1999) with
a final year at Georgetown University Law Center in Washington, D.C. Mr. Lee is well qualified to serve as Lead Director because
of his membership in the New York State Bar and extensive experience in both legal and investment sectors across various asset classes,
demonstrating significant expertise in capital markets.

Dr. Alcide Barberis has been a Director of the Company as
of the Closing of the Business Combination. He is a biotech entrepreneur, Board Member and Executive with over 25 years of
management experience in the biotechnology industry, and scientific experience in the private and public research sectors. He is
currently CEO & Director of Mabylon AG (since 2017). Before joining